You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Legacy Pharma Usa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LEGACY PHARMA USA, and what generic and branded alternatives to LEGACY PHARMA USA drugs are available?

LEGACY PHARMA USA has two approved drugs.

Summary for Legacy Pharma Usa

US Patents:	0
Tradenames:	1
Ingredients:	1
NDAs:	2

Drugs and US Patents for Legacy Pharma Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	TABLET;ORAL	020397-001	Nov 27, 1996	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-002	Aug 29, 2002	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	TABLET;ORAL	020397-002	Feb 4, 2000		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-001	Aug 29, 2002	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-003	Aug 29, 2002	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Legacy Pharma Usa

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-001	Aug 29, 2002	6,455,557	⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-002	Aug 29, 2002	6,455,557	⤷ Subscribe
Legacy Pharma Usa	ZANAFLEX	tizanidine hydrochloride	CAPSULE;ORAL	021447-003	Aug 29, 2002	6,455,557	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for LEGACY PHARMA USA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	2 mg, 4 mg and 6 mg	➤ Subscribe	2007-08-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.